Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

NPR News Now

NPR News: 11-14-2025 2PM EST

14 Nov 2025

Transcription

Chapter 1: What is the main topic discussed in this episode?

1.229 - 19.678 Lakshmi Singh

Live from NPR News, I'm Lakshmi Singh. The 2020 election interference case against President Trump and allies in Georgia has a new prosecutor. Peter Skandalakis, executive director of the Prosecuting Attorneys Council of Georgia, is taking over from Fulton County District Attorney Fannie Willis.

0

20.339 - 29.093 Lakshmi Singh

Willis was disqualified because of an appearance of impropriety stemming from an intimate relationship with a lead investigative prosecutor.

0

Chapter 2: What recent developments are there in the Georgia election interference case?

29.748 - 43.166 Lakshmi Singh

Schools in the Charlotte, North Carolina area are reassuring families after news that Border Patrol agents will soon be arriving in the city. James Farrell of Member Station WFAE has more on the district's message to the community.

0

43.287 - 54.642 James Farrell

Charlotte Mecklenburg Schools says the district hasn't been notified of any planned enforcement activity. CMS board member Liz Monterey Duvall says she's concerned about children from immigrant families missing school.

0

54.622 - 62.152 Liz Monterey Duvall

It's devastating. I'm a daughter of immigrants and I'm very protective of our students and our kids and I'm worried about absenteeism and learning loss.

0

62.292 - 76.191 James Farrell

CMS says it follows federal and state laws that guarantee all children the right to public education regardless of immigration status. Latinos make up the second largest group of CMS students. For NPR News, I'm James Farrell in Charlotte.

0

77.251 - 89.553 Lakshmi Singh

A National Institutes of Health employee who has been criticized or has criticized, rather, Trump administration health policies has been put on leave. NPR's Rob Stein reports on the action against the employee.

89.673 - 120.724 Rob Stein

The NIH put Jenna Norton on indefinite paid administrative leave on her first day back to work from the government shutdown. Norton, a program director at the National Institute of Diabetes and Digestive and Kidney Diseases, has been a vocal critic of cuts and new policies at the NIH. The NIH did not give Norton an explanation, but in a statement to NPR, an administration official said, quote,

120.704 - 132.553 Rob Stein

Radical leftist Jenna Norton chooses to constantly criticize this administration even when she's supposed to be working, unquote. Rob Stein, NPR News.

133.141 - 143.72 Lakshmi Singh

The Trump administration has been discussing this week how to reduce prices on household items such as coffee. Harvest Public Media's Skylar Rossi explains how tariffs have put a squeeze on coffee shops.

143.74 - 155.841 Skylar Rossi

Broadway Roasting Company in Kansas City, Missouri, roasts coffee from all over the world. Co-owner John Cates says he's paid at least a 10 percent tariff on most of the coffee beans he's purchased this year.

Chapter 3: How are schools in Charlotte responding to Border Patrol activities?

181.758 - 209.841 Lakshmi Singh

The CEO, credited with expanding Walmart's economic and technological footprint over the last decade, is leaving the company. Today, Walmart announced that Doug McMillan, who is 59, plans to retire early next year. As of February, John Ferner, the 51-year-old head of Walmart's U.S. operations, will take the reins of the retail giant. Both executives have been with Walmart their entire careers.

0

209.821 - 230.908 Lakshmi Singh

McMillan may not be leaving the company anytime soon. He is expected to remain on the board. A new survey shows one in eight adults in the U.S. is currently taking the drug Ozempic, Wegovy, or similar weight loss medications. NPR's Sydney Lepkin reports that's according to the nonpartisan research organization KFF.

0

231.028 - 251.888 Sydney Lepkin

The number of adults taking GLP-1 drugs, which include Ozempic, Wegovy, Zephound, and Manjaro, is going up. It went from 6% a year and a half ago to 12% now. People are taking the drugs for chronic conditions like type 2 diabetes and heart disease, as well as for weight loss. Here's Ashley Kurtzinger, a pollster at KFF.

0

252.148 - 263.727 Ashley Kurtzinger

What was really striking to us is that there wasn't one demographic group that was kind of driving the increase. It looked like there was a pretty steady increase in use across demographic groups.

0

263.967 - 278.961 Sydney Lepkin

Although most people taking these drugs say they have some insurance coverage for them, more than half say the drugs are difficult to afford. KFF conducted the poll between October 27th and November 2nd. Sydney Lepkin, NPR News. I'm Lakshmi Singh, NPR News.

Comments

There are no comments yet.

Please log in to write the first comment.